Edwards, J. (2018). CD103+ Tumor-Resident CD8+ T Cells Are Associated with Improved Survival in Immunotherapy-Naïve Melanoma Patients and Expand Significantly During Anti-PD-1 Treatment. The American Association for Cancer Research (AACR).
Chicago Style (17th ed.) CitationEdwards, J. CD103+ Tumor-Resident CD8+ T Cells Are Associated with Improved Survival in Immunotherapy-Naïve Melanoma Patients and Expand Significantly During Anti-PD-1 Treatment. The American Association for Cancer Research (AACR), 2018.
MLA (9th ed.) CitationEdwards, J. CD103+ Tumor-Resident CD8+ T Cells Are Associated with Improved Survival in Immunotherapy-Naïve Melanoma Patients and Expand Significantly During Anti-PD-1 Treatment. The American Association for Cancer Research (AACR), 2018.